EFFECTS OF HEPATITIS-B AND HEPATITIS-C VIRUS-REPLICATION ON THE ACTIONS OF INTERFERON

被引:4
作者
FOSTER, GR [1 ]
THOMAS, HC [1 ]
机构
[1] ST MARYS HOSP,SCH MED,DEPT MED,LONDON W2 1PG,ENGLAND
关键词
HEPATITIS B; HEPATITIS C; INTERFERON;
D O I
10.1016/0166-3542(94)90061-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Many patients chronically infected with hepatitis B or C do not respond to interferon therapy. For hepatitis B infections it is now clear that a viral factor down regulates the cells ability to respond to interferon and hence prevents effective therapy in some patients. In chronic hepatitis C infections, interferon therapy leads to the selection of interferon-resistant viral strains, but the mechanism of this resistance is not yet known.
引用
收藏
页码:131 / 136
页数:6
相关论文
共 15 条
[1]   TREATMENT OF CHRONIC HEPATITIS-C WITH RECOMBINANT INTERFERON-ALFA - A MULTICENTER RANDOMIZED, CONTROLLED TRIAL [J].
DAVIS, GL ;
BALART, LA ;
SCHIFF, ER ;
LINDSAY, K ;
BODENHEIMER, HC ;
PERRILLO, RP ;
CAREY, W ;
JACOBSON, IM ;
PAYNE, J ;
DIENSTAG, JL ;
VANTHIEL, DH ;
TAMBURRO, C ;
LEFKOWITCH, J ;
ALBRECHT, J ;
MESCHIEVITZ, C ;
ORTEGO, TJ ;
GIBAS, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (22) :1501-1506
[2]   EXPRESSION OF THE TERMINAL PROTEIN REGION OF HEPATITIS-B VIRUS INHIBITS CELLULAR-RESPONSES TO INTERFERON-ALPHA AND INTERFERON-GAMMA AND DOUBLE-STRANDED-RNA [J].
FOSTER, GR ;
ACKRILL, AM ;
GOLDIN, RD ;
KERR, IM ;
THOMAS, HC ;
STARK, GR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (07) :2888-2892
[3]   EXPRESSION OF THE TERMINAL PROTEIN OF HEPATITIS-B VIRUS IS ASSOCIATED WITH FAILURE TO RESPOND TO INTERFERON THERAPY [J].
FOSTER, GR ;
GOLDIN, RD ;
HAY, A ;
MCGARVEY, MJ ;
STARK, GR ;
THOMAS, HC .
HEPATOLOGY, 1993, 17 (05) :757-762
[4]   HCV INFECTION, HEPATIC HLA DISPLAY AND COMPOSITION OF THE MONONUCLEAR CELL INFLAMMATORY INFILTRATE IN CHRONIC-ALCOHOLIC LIVER-DISEASE [J].
FRENI, MA ;
AJELLO, A ;
RESTA, ML ;
GAETA, GB ;
SPADARO, A ;
FAVA, A ;
CALAPRISTI, I ;
ALESSI, N ;
FERRAU, O .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1991, 21 (06) :586-591
[5]   ANTIVIRAL THERAPY - HEPATITIS-B [J].
JACYNA, MR ;
THOMAS, HC .
BRITISH MEDICAL BULLETIN, 1990, 46 (02) :368-382
[6]   RANDOMIZED CONTROLLED TRIAL OF INTERFERON-ALPHA (LYMPHOBLASTOID INTERFERON) IN CHRONIC NON-A-HEPATITIS NON-B-HEPATITIS [J].
JACYNA, MR ;
BROOKS, MG ;
LOKE, RHT ;
MAIN, J ;
MURRAYLYON, IM ;
THOMAS, HC .
BRITISH MEDICAL JOURNAL, 1989, 298 (6666) :80-82
[7]   2ND PROTEASOME-RELATED GENE IN THE HUMAN MHC CLASS-II REGION [J].
KELLY, A ;
POWIS, SH ;
GLYNNE, R ;
RADLEY, E ;
BECK, S ;
TROWSDALE, J .
NATURE, 1991, 353 (6345) :667-668
[8]   ADENOVIRUS VAI RNA ANTAGONIZES THE ANTIVIRAL ACTION OF INTERFERON BY PREVENTING ACTIVATION OF THE INTERFERON-INDUCED ELF-2-ALPHA KINASE [J].
KITAJEWSKI, J ;
SCHNEIDER, RJ ;
SAFER, B ;
MUNEMITSU, SM ;
SAMUEL, CE ;
THIMMAPPAYA, B ;
SHENK, T .
CELL, 1986, 45 (02) :195-200
[9]   HEPATIC HLA-ANTIGEN DISPLAY IN CHRONIC HEPATITIS-B VIRUS-INFECTION - RELATION TO HEPATIC EXPRESSION OF HBV GENOME GENE-PRODUCTS AND LIVER HISTOLOGY [J].
LAU, JYN ;
BIRD, GLA ;
NAOUMOV, NV ;
WILLIAMS, R .
DIGESTIVE DISEASES AND SCIENCES, 1993, 38 (05) :888-895
[10]   THE DEGREE OF VARIABILITY IN THE AMINO TERMINAL REGION OF THE E2/NS1 PROTEIN OF HEPATITIS-C VIRUS CORRELATES WITH RESPONSIVENESS TO INTERFERON THERAPY IN VIREMIC PATIENTS [J].
OKADA, S ;
AKAHANE, Y ;
SUZUKI, H ;
OKAMOTO, H ;
MISHIRO, S .
HEPATOLOGY, 1992, 16 (03) :619-624